ASCCP and NCI Publish Guidance in the Journal of Lower Genital Tract Disease; BD Onclarity HPV Assay Identifies Risk by HPV Type for Tailored Management CLARKSBURG, MARYLAND / ACCESS Newswire / ...

JANUARY is cervical cancer awareness month in Ireland – with around 250 women being diagnosed with the illness every year. It ...

Cervical cancer screening traditionally relies on the Pap smear and HPV-DNA tests. While effective, these methods are fraught with challenges, including variability in human interpretation, false ...

CervicalCheck clinical director says high-grade pre-cancer abnormalities in 25-year-olds has fallen from 5% to 1% thanks to ...

Among female patients with positive human papillomavirus (HPV) test results and negative intraepithelial lesion or malignancy ...

Cervical cancer, the fourth most common cancer in women, is closely linked to persistent HPV infections. Early detection ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Getting the HPV vaccine in early adolescence may lower the risk of HPV-related cancers before exposure occurs. Learn about ...

BD Onclarity™ HPV assay adheres to new guidelines by identifying more individual types of HPV than any other test on the market ... to the American Society for Colposcopy and Cervical Pathology ...

Dr Nóirín Russell said that, if a woman’s screening results indicate abnormalities, they are sent for a follow-up colposcopy test. “The change is quite dramatic,” she said. “Before this ...